Article summary
This week's edition of Life Sciences weekly highlights includes news that the European Association Medical devices of Notified Bodies (Team-NB) has published a framework for the verification process for Class D in vitro diagnostic medical devices by Notified Bodies in the absence of designated EU Reference Laboratories alongside a best practice guide on the submission of Technical Documentation under Annexes II and III of Regulation (EU) 2017/745 (the Medical Devices Regulation), the European Commission issued a statement of objections to Teva in relation to its multiple sclerosis drug Copaxone, the National Institute for Health and Care Excellence and the Medicines and Healthcare products Regulatory Agency were awarded £1.8m to explore digital mental health tools, £10.65m in additional funding was given to a new vaccine innovation centre in Darlington, and six international health technology assessment bodies have formed a partnership to improve access to healthcare.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial
Access this content for free with a 7 day trial of LexisNexis and benefit from:
- Instant clarification on points of law
- Smart search
- Workflow tools
- 42 practice areas
Get your quote today and take step closer to being able to benefit from:
- Instant clarification on points of law
- Smart search
- Workflow tools
- 36 practice areas
Get a quote for Lexis+
* denotes a required field
CONTACT US
